Literature DB >> 21271564

Molecular dynamics of the cryomilled base and hydrochloride ziprasidones by means of dielectric spectroscopy.

K Kaminski1, K Adrjanowicz, Z Wojnarowska, K Grzybowska, L Hawelek, M Paluch, D Zakowiecki, J Mazgalski.   

Abstract

Cryomilling was applied to obtain amorphous forms of the base ziprasidone and its hydrochloride salt. Complete amorphization of both samples was confirmed by differential scanning calorimetry and X-ray measurements. As it turned out, cryogrinding is very effective way to obtain these drugs in the amorphous state, especially because melting of both ziprazidones accompanies significant chemical decomposition as revealed by ultra performance liquid chromatography examination. Consequently, the glassy state cannot be reached in conventional way, that is, by supercooling of melt. Broadband dielectric relaxation measurements were performed on both drugs to describe their molecular dynamics above as well as below their glass transition temperatures (T(g)). We found out that ziprasidone base and its hydrochloride salt differ in T(g) in the same way as it was previously reported for tramadol monohydrate and its hydrochloride. Moreover, our dielectric studies revealed that molecular mobility is not the main factor controlling kinetics of crystallization of both ziprasidones above their T(g) . Below the T(g) relaxation related to water as well as secondary relaxation process originating from the intermolecular interaction (Johari-Goldstein) were identified in the loss spectra of both materials. We have demonstrated that except of local mobility, water is the dominant factor moving both ziprasidones toward recrystallization process. Finally, we have also carried out solubility measurements to show that dissolution rate of the amorphous ziprasidones is much higher with respect to the crystalline samples.
Copyright © 2011 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21271564     DOI: 10.1002/jps.22479

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  The improvement of the dissolution rate of ziprasidone free base from solid oral formulations.

Authors:  Daniel Zakowiecki; Krzysztof Cal; Kamil Kaminski; Karolina Adrjanowicz; Lech Swinder; Ewa Kaminska; Grzegorz Garbacz
Journal:  AAPS PharmSciTech       Date:  2015-01-16       Impact factor: 3.246

2.  Effect of cryogrinding on chemical stability of the sparingly water-soluble drug furosemide.

Authors:  Karolina Adrjanowicz; Kamil Kaminski; Katarzyna Grzybowska; Lukasz Hawelek; Marian Paluch; Irena Gruszka; Daniel Zakowiecki; Wieslaw Sawicki; Przemyslaw Lepek; Wojciech Kamysz; Lukasz Guzik
Journal:  Pharm Res       Date:  2011-06-25       Impact factor: 4.200

3.  Molecular Dynamics and Physical Stability of Ibuprofen in Binary Mixtures with an Acetylated Derivative of Maltose.

Authors:  Katarzyna Grzybowska; Andrzej Grzybowski; Justyna Knapik-Kowalczuk; Krzysztof Chmiel; Krzysztof Woyna-Orlewicz; Joanna Szafraniec-Szczęsny; Agata Antosik-Rogóż; Renata Jachowicz; Katarzyna Kowalska-Szojda; Piotr Lodowski; Marian Paluch
Journal:  Mol Pharm       Date:  2020-07-09       Impact factor: 4.939

4.  Studies on the Vitrified and Cryomilled Bosentan.

Authors:  Aldona Minecka; Krzysztof Chmiel; Karolina Jurkiewicz; Barbara Hachuła; Rafał Łunio; Daniel Żakowiecki; Kinga Hyla; Bartłomiej Milanowski; Kajetan Koperwas; Kamil Kamiński; Marian Paluch; Ewa Kamińska
Journal:  Mol Pharm       Date:  2021-12-01       Impact factor: 4.939

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.